Has Christopher Martin, MD received payments from drug or device companies?

Yes. Drug and device makers reported $130,972 in general payments to Christopher Martin, MD across 215 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Christopher Martin, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Christopher Martin, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Christopher Martin, MD

Orthopaedic Surgery · Minneapolis, MNNPI 1710272042

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $94,600 of the $130,972 with a category attached, or 72.2%. Medtronic accounts for 84.6% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $41,121, more than ten times the $1,078 reported in 2019. Among orthopaedic surgery clinicians in MN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$130,972in general payments, 2019–2025

Across 215 payments — averaging $609.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$111K
Alphatec Spine, Inc$9K
Si-bone, Inc.$7K
Providence Medical Technology, Inc.$2K
Smaio SA$1K
Foundation Medical, LLC$903
plus $430 from 2 others

$144,931in research payments, 2019–2025

Across 33 payments — averaging $4391.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Si-bone, Inc.$145K

What the payments were for

Consulting fees$94,60072%
Travel & lodging$30,80524%
Food & beverage$5,5674%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	158	$110,781
Alphatec Spine, Inc	24	$9,354
Si-bone, Inc.	13	$6,538
Providence Medical Technology, Inc.	7	$1,592
Smaio SA	4	$1,372
Foundation Medical, LLC	5	$903
Arthrex	3	$288
Zimmer Biomet	1	$142

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

INFINITY OCCIPITOCERVICAL UPPER THORACIC SYSTEM$84,093
CATALYFT PL EXPANDABLE INTERBODY SYSTEM$9,628
Other - Miscellaneous$8,202
IFUSE IMPLANT SYSTEM$6,208
ENDOSKELETON TC NANOLOCK SURFACE TECHNOLOGY$1,128
DIVERGENCE-L$983
CD HORIZON$754
ZEVO ANTERIOR CERVICAL PLATE SYSTEM$600
UNID_PASS$268
CLYDESDALE$257
Mazor X Stealth Edition$233
Persona Revision$142

How this compares

$130,972 in reported general payments places this provider in the 90th percentile of 533 orthopaedic surgery providers in Minnesota.

See all orthopaedic surgery providers in Minnesota →

Medicare billing

Part B allowed, 2024

$260,756

Medicare patients

211

Services billed

892

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Gabapentin	121	$1,053
Methocarbamol	38	$283
Methylprednisolone	30	$213
Tizanidine Hcl	41	$196
Hydroxyzine Hcl	11	$120
Cyclobenzaprine Hcl	16	$95
Meloxicam	13	$43

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Minneapolis

David PollyMinneapolis$3.3M
Ensor TransfeldtMinneapolis$2.3M
Manuel PintoMinneapolis$1.7M
Joseph PerraMinneapolis$1.6M
Timothy GarveyMinneapolis$1.6M
Amir MehbodMinneapolis$1.3M
David TemplemanMinneapolis$361K
Patrick YoonMinneapolis$203K
Elizabeth ArendtMinneapolis$111K
Emily WagstromMinneapolis$71K

See the full list for Minnesota →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →